Table 5.
PLC phase | ALC phase | |||||
---|---|---|---|---|---|---|
LPD | RPD | p value | LPD | RPD | p value | |
Patients, n | 13 | 18 | 26 | 57 | ||
PPPD/whipple | 10/3 | 15/3 | 0.68 | 22/4 | 49/8 | > 0.99 |
Operative time, min | 377 (354–454) | 381 (340–407) | 0.56 | 289 (257–307) | 286 (252–313) | 0.91 |
Blood loss, mL | 200 (0–350) | 100 (100–100) | 0.85 | 50 (0–200) | 100 (0–100) | 0.63 |
Open conversion | 1 (8%) | 0 | 0.42 | 2 (8%) | 2 (4%) | 0.59 |
Harvested lymph nodes, n | 17 (7.5–22.5) | 14.5 (8–21) | 0.62 | 14.5 (9–21.3) | 13 (10–19) | 0.69 |
CD grade | 0.18 | 0.63 | ||||
0 | 4 (31%) | 10 (56%) | 12 (46%) | 29 (51%) | ||
I | 2 (15%) | 0 | 3 (12%) | 5 (9%) | ||
II | 1 (8%) | 5 (28%) | 9 (35%) | 12 (21%) | ||
IIIa | 3 (23%) | 2 (11%) | 1 (4%) | 7 (12%) | ||
IIIb | 1 (8%) | 0 | 0 | 0 | ||
IVa | 1 (8%) | 1 (6%) | 1 (4%) | 2 (4%) | ||
IVb | 1 (8%) | 0 | 0 | 1 (2%) | ||
V | 0 | 0 | 0 | 1 (2%) | ||
Major complication, CD ≧ III | 6 (46%) | 3 (17%) | 0.11 | 2 (8%) | 12 (21%) | 0.53 |
POPF | 0.18 | 0.44 | ||||
Biochemical | 2 (15%) | 8 (44%) | 9 (35%) | 24 (42%) | ||
B | 3 (23%) | 1 (6%) | 6 (23%) | 10 (18%) | ||
C | 0 | 1 (6%) | 0 | 0 | ||
DGE, grade B + C | 3 (23%) | 2 (11%) | 0.63 | 1 (4%) | 7 (12%) | 0.71 |
PPH, grade B + C | 2 (15%) | 3 (17%) | > 0.99 | 2 (8%) | 6 (11%) | > 0.99 |
Bile leak | 3 (23%) | 0 | 0.06 | 0 | 5 (9%) | 0.17 |
Fluid collection | 4 (31%) | 2 (11%) | 0.21 | 2 (8%) | 11 (19%) | 0.21 |
Wound infection | 5 (38%) | 1 (6%) | 0.06 | 2 (8%) | 8 (14%) | 0.49 |
Reoperation | 1 (8%) | 0 | 0.42 | 0 | 1 (2%) | > 0.99 |
Hospital stay, days | 17 (12.5–30) | 13 (11–16.3) | 0.09 | 15 (12–20) | 15 (11–23) | 0.90 |
Re-admission | 2 (15%) | 3 (17%) | > 0.99 | 0 | 5 (9%) | 0.17 |
PLC pre-learning curve, ALC after-learning curve, PPPD pylorus preserving pancreaticoduodenectomy, CD Clavien–Dindo, DGE delayed gastric emptying, PPH postpancreatectomy hemorrhage, POPF postoperative pancreatic fistula.